Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 27 | 2024 | 48 | 4.950 |
Why?
|
| Radiosurgery | 29 | 2024 | 56 | 4.330 |
Why?
|
| Embolization, Therapeutic | 8 | 2024 | 23 | 1.410 |
Why?
|
| Arteriovenous Fistula | 5 | 2020 | 12 | 1.240 |
Why?
|
| Central Nervous System Vascular Malformations | 6 | 2020 | 10 | 1.220 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2019 | 9 | 1.150 |
Why?
|
| Treatment Outcome | 25 | 2024 | 1604 | 0.920 |
Why?
|
| Intracranial Aneurysm | 3 | 2024 | 10 | 0.880 |
Why?
|
| Retrospective Studies | 27 | 2024 | 2544 | 0.770 |
Why?
|
| Arachnoid Cysts | 1 | 2022 | 1 | 0.750 |
Why?
|
| Spinal Cord | 1 | 2022 | 114 | 0.700 |
Why?
|
| Hemangioblastoma | 1 | 2019 | 1 | 0.630 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 3 | 0.630 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 4 | 0.630 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2019 | 92 | 0.580 |
Why?
|
| Middle Cerebral Artery | 1 | 2014 | 14 | 0.450 |
Why?
|
| Follow-Up Studies | 14 | 2023 | 1067 | 0.420 |
Why?
|
| Male | 31 | 2024 | 23409 | 0.400 |
Why?
|
| Humans | 40 | 2024 | 43102 | 0.400 |
Why?
|
| Adult | 26 | 2024 | 13872 | 0.390 |
Why?
|
| Middle Aged | 23 | 2024 | 12222 | 0.380 |
Why?
|
| Cohort Studies | 13 | 2024 | 1759 | 0.380 |
Why?
|
| Child | 15 | 2024 | 3443 | 0.360 |
Why?
|
| Postoperative Hemorrhage | 5 | 2019 | 15 | 0.350 |
Why?
|
| Carotid Artery, External | 1 | 2011 | 5 | 0.350 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 26 | 0.340 |
Why?
|
| Stents | 1 | 2011 | 67 | 0.340 |
Why?
|
| Adolescent | 17 | 2024 | 6081 | 0.330 |
Why?
|
| Aged | 15 | 2024 | 8214 | 0.330 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2009 | 6 | 0.310 |
Why?
|
| Propofol | 1 | 2009 | 8 | 0.310 |
Why?
|
| Female | 28 | 2024 | 24698 | 0.310 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 27 | 0.310 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2008 | 3 | 0.290 |
Why?
|
| Blood Vessels | 1 | 2008 | 36 | 0.270 |
Why?
|
| Ganglia, Spinal | 1 | 2007 | 42 | 0.250 |
Why?
|
| Young Adult | 10 | 2024 | 5080 | 0.200 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2023 | 3 | 0.200 |
Why?
|
| Neurilemmoma | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cavernous Sinus | 2 | 2020 | 3 | 0.200 |
Why?
|
| Cerebral Hemorrhage | 3 | 2019 | 104 | 0.200 |
Why?
|
| Puerto Rico | 3 | 2019 | 1413 | 0.200 |
Why?
|
| Aged, 80 and over | 7 | 2023 | 2853 | 0.190 |
Why?
|
| Cerebral Angiography | 2 | 2014 | 7 | 0.190 |
Why?
|
| Cerebral Ventricles | 1 | 2022 | 23 | 0.190 |
Why?
|
| Polyvinyls | 1 | 2021 | 6 | 0.170 |
Why?
|
| Subarachnoid Space | 1 | 2019 | 3 | 0.160 |
Why?
|
| Basal Ganglia | 1 | 2019 | 21 | 0.150 |
Why?
|
| Thalamus | 1 | 2019 | 34 | 0.150 |
Why?
|
| Seizures | 1 | 2019 | 79 | 0.140 |
Why?
|
| Hematoma, Subdural | 1 | 2017 | 1 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2017 | 33 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2024 | 1546 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 193 | 0.130 |
Why?
|
| Postoperative Complications | 4 | 2020 | 263 | 0.120 |
Why?
|
| Risk Factors | 6 | 2020 | 3994 | 0.120 |
Why?
|
| Prognosis | 4 | 2020 | 861 | 0.120 |
Why?
|
| Basal Ganglia Hemorrhage | 1 | 2014 | 2 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 16 | 0.110 |
Why?
|
| Radiation Injuries | 3 | 2019 | 23 | 0.110 |
Why?
|
| Color | 1 | 2014 | 38 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 440 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 539 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 89 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 245 | 0.100 |
Why?
|
| Internationality | 3 | 2017 | 37 | 0.100 |
Why?
|
| Age Factors | 3 | 2019 | 1154 | 0.080 |
Why?
|
| Injections, Intra-Arterial | 1 | 2009 | 5 | 0.080 |
Why?
|
| Smoking | 1 | 2014 | 1024 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2010 | 863 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 1600 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.060 |
Why?
|
| Animals | 1 | 2022 | 16992 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 23 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 1175 | 0.050 |
Why?
|
| Reoperation | 1 | 2024 | 34 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 173 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 719 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1009 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 1028 | 0.050 |
Why?
|
| ROC Curve | 1 | 2020 | 159 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2019 | 48 | 0.040 |
Why?
|
| Transverse Sinuses | 1 | 2019 | 1 | 0.040 |
Why?
|
| Brain Damage, Chronic | 1 | 2019 | 5 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 59 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 37 | 0.040 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2017 | 1 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 10 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 152 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 175 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 7 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 341 | 0.030 |
Why?
|
| Eligibility Determination | 1 | 2015 | 9 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 587 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 518 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 375 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 1472 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 1612 | 0.020 |
Why?
|